MORNINGSIDE VENTURE INVESTMENTS LTD has a total of 16 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets medical technology, environmental technology and pharmaceuticals are RENOVORX INC, BARI NASEEM and SURVIVAL TECHNOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 6 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Environmental technology | |
#3 | Pharmaceuticals | |
#4 | Engines, pumps and turbines | |
#5 | Computer technology | |
#6 | Control |
# | Name | Total Patents |
---|---|---|
#1 | Schubert Frank | 5 |
#2 | Buchman Daniela Tamar | 4 |
#3 | Tong Ling-Kang | 4 |
#4 | Terzulli Nicholas | 3 |
#5 | Hancock Jackie Joe | 3 |
#6 | Dipierro Guy | 2 |
#7 | Johnston Andrew L | 2 |
#8 | Schaller Michael P | 2 |
#9 | Hartman Adam Blake | 1 |
#10 | Peterson Bryce | 1 |
Publication | Filing date | Title |
---|---|---|
EP3801732A1 | Drug delivery methods and systems | |
US2020071191A1 | Systems and methods for water reclamation | |
AU2017373857A1 | Transdermal drug delivery devices and methods | |
AU2006235254A1 | Use of FRIL proteins for reducing the production of pro-inflammatory cytokines | |
AU2004289329A1 | Methods and compositions for the treatment of B cell lymphomas and other cancers |